Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 3204-3211, June 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balosso, J.
Right arrow Articles by Favaudon, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balosso, J.
Right arrow Articles by Favaudon, V.

Additive and Supraadditive Interaction between Ionizing Radiation and Pazelliptine, a DNA Topoisomerase Inhibitor, in Chinese Hamster V-79 Fibroblasts1

Jacques Balosso2, Nicole Giocanti and Vincent Favaudon3

Unité 219 INSERM, Institut Curie-Biologie, Labs. 110–112, Centre Universitaire, 91405 Orsay Cedex, France

The cytotoxic effect of the 9-azaellipticine derivative pazelliptine in combination with {gamma}-ray irradiation was investigated using Chinese hamster V-79 cells in culture. {gamma}-ray irradiation and drug treatment (1-h drug exposure) were applied at 1-h intervals for partial DNA damage recovery in growth medium. Isobologram analysis of the clonogenic potential gave evidence of supraadditive interaction in the radiation -> drug sequence with 10% survival as an endpoint. No synergistic potentiation was observed at higher survival or as pazelliptine was applied first. Pazelliptine abolished the low-dose shoulder characteristic of asynchronous cell response to {gamma}-rays. Although rejoining of radiation-induced DNA strand breaks was completed at the time of drug exposure, pazelliptine brought about a larger amount of DNA strand breaks in preirradiated than in nonirradiated cells.

The time and dose dependencies of DNA strand break formation and repair with radiation and/or pazelliptine were analyzed by neutral and alkaline filter elution. Pazelliptine in the micromolar range showed the same pattern of double-stranded cleavable complex formation as expected of a DNA topoisomerase II-targeting agent. At a low concentration of pazelliptine, however, protein-concealed breaks were mostly in the form of single-stranded adducts. Such single-stranded complexes have been reported to occur with some topoisomerase II-targeting drugs; their properties are also reminiscent of those induced by the topoisomerase I poison, camptothecin. It is proposed that topoisomerase poisoning interacts with the repair of radiation-induced lesions.

1 This work was supported by a research fellowship from the Centre Hospitalier Universitaire de Montpellier to J. B., by financial aid from the Institut National de la Santé et de la Recherche Médicale, and by a grant (No. 89-21-5) from the Institut Curie.

2 Present address: Service de Radiothérapie, Hôpital Tenon, 4 Rue de la Chine, 75970 Paris Cedex 20, France.

3 To whom requests for reprints should be addressed.

Received 11/21/90. Accepted 4/ 2/91.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
C. Godon, F. P. Cordelieres, D. Biard, N. Giocanti, F. Megnin-Chanet, J. Hall, and V. Favaudon
PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility
Nucleic Acids Res., August 1, 2008; 36(13): 4454 - 4464.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G. Noel, C. Godon, M. Fernet, N. Giocanti, F. Megnin-Chanet, and V. Favaudon
Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis.
Mol. Cancer Ther., March 1, 2006; 5(3): 564 - 574.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. Reis, N. Giocanti, C. Hennequin, F. Megnin-Chanet, M. Fernet, R. Filomenko, A. Bettaieb, E. Solary, and V. Favaudon
A role for PKC{zeta} in potentiation of the topoisomerase II activity and etoposide cytotoxicity by wortmannin
Mol. Cancer Ther., October 1, 2005; 4(10): 1457 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. MIYAMOTO, T. T. HUANG, S. WUERZBERGER-DAVIS, W. G. BORNMANN, J. J. PINK, C. TAGLIARINO, T. J. KINSELLA, and D. A. BOOTHMAN
Cellular and Molecular Responses to Topoisomerase I Poisons: Exploiting Synergy for Improved Radiotherapy
Ann. N.Y. Acad. Sci., December 1, 2000; 922(1): 274 - 292.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.